Clinical trial

Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

NCT07683585

Study summary

ClinicalTrials.gov

Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Losartan + Hydrochlorothiazide Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Amlodipine + Azilsartan Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-04-01

PhaseNA

Conditions

Hypertensionunresolved

Coronary Arterial Diseaseunresolved

Percutaneous Coronary Interventionunresolved

Interventions

Losartan + HydrochlorothiazideDRUG

Amlodipine + AzilsartanDRUG

Sponsors & collaborators

National Medical Research Center for Therapy and Preventive Medicinelead sponsor

Mapped research locations

MoscowRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07683585 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.